A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma-Reference-Cited by-同舟云学术

A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma

Published:2008-12 Issue:6 Volume:49 Page:1055-1061
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

de Lima Vicência M.R.,Oliveira Claudia P.M.S.,Alves Venancio A.F.,Chammas Maria Cristina,Oliveira Ellen Pierre,Stefano José Tadeu,de Mello Evandro Sobroza,Cerri Giovanni Guido,Carrilho Flair José,Caldwell Stephen H.

Publisher

Elsevier BV

Subject

Hepatology

Reference62 articles.

1. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterology,2004

2. Management of hepatocellular cancer (AASLD practice guideline);Bruix;Hepatology,2005

3. Hepatocellular cancer in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

4. Rising incidence of hepatocellular carcinoma in the Unites States;El-Serag;N Engl J Med,1999

5. Mortality and hospital utilization for hepatocellular cancer in the United States;Kim;Gastroenterology,2005

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review;International Immunopharmacology;2024-05

2. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease;World Journal of Hepatology;2024-01-27

3. Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment;npj Regenerative Medicine;2023-11-07

4. PRECLINICAL MODELS OF LIVER CÂNCER;Arquivos de Gastroenterologia;2023-09

5. P53 and VEGF are promising biomarkers for sorafenib efficacy in an experimental model of NASH-related HCC;Journal of Molecular Histology;2023-08-21